XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Interim Condensed Consolidated Statement of Operations (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses    
General and administrative $ 3,317,036 $ 3,066,951
Research and development 12,066,919 8,656,439
Total operating expenses 15,383,955 11,723,390
Operating loss (15,383,955) (11,723,390)
Other income    
Grant income 25,000
Research and development incentive income 733,590 810,730
Interest income, net 1,267,618 4,910
Foreign exchange gain, net 365,983 55,363
Total other income, net 2,392,191 871,003
Net loss before provision for income taxes (12,991,764) (10,852,387)
Income tax recovery (expense), current 20,046 (29,980)
Net loss and comprehensive loss $ (12,971,718) $ (10,882,367)
Net Loss per share    
Basic and diluted $ (0.17) $ (0.14)
Weighted average number of shares outstanding    
Basic and diluted $ 77,977,112 $ 75,997,738